Cardiovascular Tissue

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Heart valve, Quantity: 1 U

Available from:

Victorian Institute of Forensic Medicine T/A Donor Tissue Bank of Victoria

INN (International Name):

Pulmonary Valve, Cryopreserved - L

Pharmaceutical form:

Graft

Composition:

Excipient Ingredients: dimethyl sulfoxide; glucose monohydrate; ascorbic acid; polysorbate 80; sodium chloride; dibasic sodium phosphate; guanine hydrochloride monohydrate; monobasic potassium phosphate; dried magnesium sulfate; aminobenzoic acid; adenine sulfate dihydrate; alanine; arginine hydrochloride; aspartic acid; Biotin; cholesterol; calcium chloride dihydrate; cysteine hydrochloride monohydrate; cystine; choline chloride; calcium pantothenate; deoxyribose; ergocalciferol; ferric nitrate nonahydrate; folic acid; glycine; glutamic acid; glutathione; histidine hydrochloride monohydrate; hydroxyproline; sodium hypoxanthine; isoleucine; inositol; leucine; betaine; methionine; menadione; nicotinic acid; nicotinamide; phenolsulfonphthalein; potassium chloride; pyridoxal hydrochloride; pyridoxine hydrochloride; phenylalanine; proline; retinol acetate; riboflavin; ribose; serine; sodium acetate; sodium bicarbonate; thymine; tyrosine disodium; thiamine hydrochloride; dl-alpha-tocopheryl phosphate disodium; threonine; tryptophan; uracil; valine; sodium xanthine; adenosine phosphate; adenosine triphosphate disodium trihydrate

Administration route:

Implant

Class:

Class 2

Therapeutic area:

Cardiovascular Tissue

Therapeutic indications:

Restoration/repair of cardiovascular tissue

Authorization status:

A

Authorization date:

2015-04-23